Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia

NCT07238400 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Eplerenone 100 mg daily
DRUG: Chlorthalidone 25 mg daily
DRUG: Potassium Placebo
DRUG: Potassium Chloride

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]